Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-12

FDA Approved: VALTREX — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for Valtrex (valacyclovir hydrochloride) filed by GlaxoSmithKline LLC under NDA020487. The action updates labeling and/o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALTREX (valacyclovir hydrochloride)

Snippet

SUPPL AP for VALTREX (VALACYCLOVIR HYDROCHLORIDE)